SYSTEMS-2: A randomised phase II study of radiotherapy dose escalation for pain control in malignant pleural mesothelioma

M. Ashton, N. O'Rourke, N. Macleod,B. Laird,J. Stobo,C. Kelly,L. Alexander,K. Franks, K. Moore, S. Currie, R. Valentine, A.J. Chalmers

Clinical and Translational Radiation Oncology(2018)

引用 0|浏览0
暂无评分
摘要
SYSTEMS-2 is a randomised study of radiotherapy dose escalation for pain control in 112 patients with malignant pleural mesothelioma (MPM). Standard palliative (20 Gy/5#) or dose escalated treatment (36 Gy/6#) will be delivered using advanced radiotherapy techniques and pain responses will be compared at week 5. Data will guide optimal palliative radiotherapy in MPM.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要